Lortab Maximum Strength Prescription Pain Reliever Launched by UCB
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Lortab Maximum Strength Prescription Pain Reliever Launched by UCB

ATLANTA, July 10, 1996-- UCB Pharma, Inc., has met the U.S. Food and Drug Administration (FDA) requirements to market Lortab 10/500 CIII (Hydrocodone* Bitartrate and Acetaminophen Tablets, USP, 10mg/500mg, *Warning: May be habit forming).

The new addition to the Lortab brand line of prescription analgesics offers patients the first 10 mg hydrocodone combination formulated to maximize therapeutic flexibility and minimize the potential for acetaminophen (APAP) toxicity, which is becoming a growing concern.

The Lortab 10/500 APAP content is lower than any other 10 mg hydrocodone combination now available. Taken every 4-6 hours, the new tablet does not exceed the generally recommended maximum acetaminophen dose of 4000 mg/day.

Like other products in the widely prescribed Lortab brand line, Lortab 10/500 provides analgesic relief in minutes that lasts for hours, with onset of action in 10-30 minutes, duration from 4-6 hours. It also offers physicians and their patients the convenience of telephone prescribing and refills. The toleration profile is similar to other narcotic analgesics, with lightheadedness and sedation among the most frequently reported adverse effects.

Lortab 10/500 also allows physicians to offer today's cost-conscious patients added relief without added expense -- average wholesale price is the same for Lortab 10/500 and Lortab 7.5/500 (Hydrocodone* Bitartrate and Acetaminophen Tablets, USP, 7.5 mg/500mg, * Warning: May be habit forming).

The new product is being introduced to oncologists, oral surgeons, orthopedic surgeons, and family practitioners nationwide by UCB Pharma's 250-member sales force. UCB Pharma, Inc., is the U.S. division of Belgian-based UCB Pharma, a multinational leader with over $600 million in annual pharmaceutical sales. The U.S. operation began with UCB's acquisition of Whitby Pharmaceuticals in 1994.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities